United States · FDA National Drug Code directory
roflumilast
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 73190-086_5500b154-77bd-3d4a-e063-6394a90ade49
- Product NDC
- 73190-086
- Form
- TABLET
- Composition / generic term
- ROFLUMILAST
- Labeler
- AvKARE
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260624
- Source listing expiry
- 20271231
Source-listed ingredients
- ROFLUMILAST — 250 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BLISTER PACK in 1 BOX (73190-086-28) / 14 TABLET in 1 BLISTER PACK (73190-086-11) · 73190-086-28
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →